Vision Retirement’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Vision Retirement's REGN Position: Q2 2026 in Review
Vision Retirement held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 243 shares worth $152K. The position accounts for 0.04% of the portfolio, ranked #147.
Vision Retirement first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $188K in Q1 2026. 1,256 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Vision Retirement held 243 shares of Regeneron Pharmaceuticals worth $152K as of Q2 2026.
- Vision Retirement left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.04% of Vision Retirement's portfolio in Q2 2026, its #147 holding.
- Vision Retirement first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Vision Retirement's Regeneron Pharmaceuticals position peaked at $188K in Q1 2026.
- 1,256 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.